REDD1 plays an important role in the pathogenesis of metabolic disorders, which are closely associated with low-grade inflammation, also known as meta-inflammation6,96, suggesting that REDD1 contributes to metabolic disorders via its promotion of NF-κB-dependent systemic inflammation. This evidence concerns the gene NFKB1 and Other metabolic disease.